Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma for Prevention of Severe COVID-19 in Elderly
NCT04479163Completed
- Sponsor
- Fundación Infant
- Start
- Jun 2020
- Primary completion
- Oct 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Randomised, double-blind trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Fundación Infant. Primary endpoint: Development of severe respiratory disease at 15 days. Started Jun 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04479163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04479163.